Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study

Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity

(2016) Sungshim L. Park et al.   CARCINOGENESIS

Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study

(2016) Jian-Min Yuan et al.   INTERNATIONAL JOURNAL OF CANCER

CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers—findings from two independent populations

(2014) Catherine A. Wassenaar et al.   CARCINOGENESIS

Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups

(2014) Sharon E. Murphy et al.   CARCINOGENESIS

Association betweenCYP2A6genetic polymorphisms and lung cancer: A meta-analysis of case-control studies

(2012) Tao Liu et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level

(2011) A. A. Strasser et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk

(2011) Catherine A. Wassenaar et al.   JNCI-Journal of the National Cancer Institute

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Nicotine Metabolism in Three Ethnic/Racial Groups with Different Risks of Lung Cancer

(2008) K. S. Derby et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION